Comparison of paravalvular aortic leak characteristics in the Medtronic CoreValve versus Edwards Sapien Valve: Paravalvular aortic leak characteristics

2018 ◽  
Vol 92 (5) ◽  
pp. 972-980 ◽  
Author(s):  
Olivia N. Gilbert ◽  
Charles H. Choi ◽  
Jodie L. Franzil ◽  
Melissa Caughey ◽  
Waqas Qureshi ◽  
...  
Keyword(s):  
Edwards Sapien ◽  
Edwards Sapien Valve ◽  
Medtronic Corevalve

scholarly journals Patient-specific image-based computer simulation for theprediction of valve morphology and calcium displacement after TAVI with the Medtronic CoreValve and the Edwards SAPIEN valve

2016 ◽  
Vol 11 (9) ◽  
pp. 1044-1052 ◽  
Author(s):  
Carl Schultz ◽  
Ramon Rodriguez-Olivares ◽  
Johan Bosmans ◽  
Thierry Lefèvre ◽  
Gianluca De Santis ◽  
...  
Keyword(s):  
Computer Simulation ◽  
Patient Specific ◽  
Valve Morphology ◽  
Edwards Sapien ◽  
Edwards Sapien Valve ◽  
Medtronic Corevalve

Abstract 17302: A Meta-Analysis of Major Adverse Cardiovascular and Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Implantation Using Edwards SAPIEN valve versus Medtronic CoreValve for Severe Aortic Stenosis

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Hemang B Panchal ◽  
Neil Barry ◽  
Samit Bhatheja ◽  
Kais Albalbissi ◽  
Timir Paul
Keyword(s):  
Severe Aortic Stenosis ◽  
Meta Analysis ◽  
Transcatheter Aortic Valve ◽  
Cerebrovascular Events ◽  
Edwards Sapien ◽  
All Cause Mortality ◽  
Edwards Sapien Valve ◽  
Medtronic Corevalve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Background: In patients with severe aortic stenosis (AS) who are at high risk for surgery, a transcatheter aortic valve implantation (TAVI) is an emerged alternative procedure using Edwards SAPIEN valve (EV) or Medtronic CoreValve (CV). The purpose of this meta-analysis is to compare early major adverse cardiovascular and cerebrovascular events (MACCE) between EV and CV. Methods: PubMed and the Cochrane Center Register of Controlled Trials were searched through May 2014. Seventeen studies (n=6211) comparing TAVI procedure that used EV (n=2693) and CV (n=3518) were included. End points were post-procedural all-cause mortality, cardiovascular mortality, myocardial infarction, stroke, major bleeding and major vascular events. The odds ratio (OR) with 95% confidence interval (CI) was computed and p<0.05 was considered as a level of significance. Results: The studies were homogeneous for all outcomes except all-cause mortality. There was no significant difference between EV and CV for post-procedural all-cause mortality (OR: 0.82, CI: 0.6-1.13, p=0.23), cardiovascular mortality (OR: 0.7, CI: 0.41-1.2. p=0.2), myocardial infarction (OR: 1.13, CI: 0.51-2.51, p=0.76), stroke (OR: 0.97, CI: 0.66-1.42, p=0.86) (Figure), major bleeding (OR: 1.13, CI: 0.81-1.58, p=0.48) and major vascular complications (OR: 1.22, CI: 0.94-1.58, p=0.14). Conclusion: The results of our meta-analysis of 6211 patients suggest that the types of valve used to perform TAVI procedures do not affect early mortality and MACCE outcomes. Further studies are needed to evaluate long-term outcomes.

scholarly journals Regurgitation after Edwards SAPIEN valve implantation: truly paravalvular or ‘supra-skirtal’?

2012 ◽  
Vol 34 (16) ◽  
pp. 1214-1214 ◽  
Author(s):  
Barbara E. Stähli ◽  
Catherine Gebhard ◽  
Volkmar Falk ◽  
Roberto Corti ◽  
Rolf Jenni ◽  
...  
Keyword(s):  
Edwards Sapien ◽  
Edwards Sapien Valve ◽  
Valve Implantation
Sign in / Sign up

Export Citation Format

Share Document